LaborGesundheitOriginaltext auf Englisch
Urolithin A boosts cyclosporine in rodent lupus study
The combination outperformed either treatment alone in a preclinical female-rodent model.
Von KI verfasst1 Quelle1 Min.
Loading…
Diagnostik, Prothesen, Impfstoffe, Genomik: die Medizin, die Lebensjahre gewinnt.
The combination outperformed either treatment alone in a preclinical female-rodent model.
It targets BCL6, which normally silences genes that can stop growth or trigger programmed cell death.
An Australian team screened 63 existing medicines in patient-derived brain cells.
The University of Surrey study identified three distinct five-year health trajectories among 12,701 UK heart-attack survivors.
Risk was about 2% with one worrisome feature, 4% with two and 18% with three or more.
Vitestro’s Aletta can handle a blood draw while one trained phlebotomist oversees up to three devices.
Mayo Clinic researchers tested the model in 275 patients and validated it in 46 patients in South Korea.
The oral probiotic was tested in diabetic mice and monkeys, not humans.
LATeNT blocks selected synapses with blue light and restores normal signaling within approximately 24 hours.
Kiel and U.S. researchers traced the block to QPRT, an enzyme involved in making the energy molecule NAD⁺.
Hokkaido University researchers linked an early interferon burst to survival after lethal viral infection in mice.
Basel researchers identified GABAergic and serotonergic brainstem neurons that promote recovery sleep in mice.
The compounds are dinitrosyl iron complexes, or DNICs, formed from nitrate and nonheme iron.
Monash researchers tracked 62 first-time users across movies, meditation, music and rest.
A Harvard team kept 3D human brain tissue models alive for nearly six years.
The MIT method still uses a small amount of DMSO, but not enough to require removal after thawing.
The University of Delaware study tracked estrogen-sensitive mechanical changes in the hippocampus across the rat reproductive cycle.
Emory researchers studied adults with mild cognitive impairment and sleep disturbances, both early dementia risk markers.